TriSalus Life Sciences (TLSI) Interest Expenses (2020 - 2026)

TriSalus Life Sciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 18.78% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $3.5 million (up 19.82% YoY), while the FY2025 annual figure was $68.7 million, up 12.07% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
• The five-year high for Interest Expenses was $1.5 million in Q2 2025, with the low at -$272000.0 in Q4 2024.
• The 5-year median for Interest Expenses is $464000.0 (2024), against an average of $616500.0.
• Peak annual rise in Interest Expenses reached 28450.0% in 2024, while the deepest fall reached 5540.0% in 2024.
• TriSalus Life Sciences' Interest Expenses stood at $1000.0 in 2022, then soared by 400.0% to $5000.0 in 2023, then sank by 5540.0% to -$272000.0 in 2024, then surged by 529.78% to $1.2 million in 2025, then rose by 22.84% to $1.4 million in 2026.
• Business Quant data shows TLSI's Interest Expenses at $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.5 million in Q3 2025.